{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:37:43Z","timestamp":1783571863020,"version":"3.55.0"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T00:00:00Z","timestamp":1564963200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T00:00:00Z","timestamp":1564963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Progetto Invecchiamento","award":["DSB.AD009.001"],"award-info":[{"award-number":["DSB.AD009.001"]}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"crossref","award":["CIP 2014.IT.05.SFOP.014\/3\/10.4\/9.2.10\/0008"],"award-info":[{"award-number":["CIP 2014.IT.05.SFOP.014\/3\/10.4\/9.2.10\/0008"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"crossref","award":["CUP G67B17000170009"],"award-info":[{"award-number":["CUP G67B17000170009"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007706","name":"Ministero dello Sviluppo Economico","doi-asserted-by":"publisher","award":["DSB.AD008.456"],"award-info":[{"award-number":["DSB.AD008.456"]}],"id":[{"id":"10.13039\/501100007706","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s10571-019-00717-0","type":"journal-article","created":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T06:02:37Z","timestamp":1564984957000},"page":"1-14","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Alternative Splicing of ALS Genes: Misregulation and Potential Therapies"],"prefix":"10.1007","volume":"40","author":[{"given":"Benedetta","family":"Perrone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"La Cognata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Sprovieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Ungaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Luisa","family":"Conforti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"And\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7590-1792","authenticated-orcid":false,"given":"Sebastiano","family":"Cavallaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,5]]},"reference":[{"key":"717_CR1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1089\/nat.2017.0682","volume":"27","author":"A Aartsma-Rus","year":"2017","unstructured":"Aartsma-Rus A et al (2017) Development of exon skipping therapies for duchenne muscular dystrophy: a critical review and a perspective on the outstanding issues. Nucleic Acid Ther 27:251\u2013259. \nhttps:\/\/doi.org\/10.1089\/nat.2017.0682","journal-title":"Nucleic Acid Ther"},{"key":"717_CR2","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jocn.2015.12.039","volume":"32","author":"H Aizawa","year":"2016","unstructured":"Aizawa H, Hideyama T, Yamashita T, Kimura T, Suzuki N, Aoki M, Kwak S (2016) Deficient RNA-editing enzyme ADAR2 in an amyotrophic lateral sclerosis patient with a FUS(P525L) mutation. J Clin Neurosci 32:128\u2013129. \nhttps:\/\/doi.org\/10.1016\/j.jocn.2015.12.039","journal-title":"J Clin Neurosci"},{"key":"717_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2147\/TACG.S71506","volume":"7","author":"V Arechavala-Gomeza","year":"2014","unstructured":"Arechavala-Gomeza V, Khoo B, Aartsma-Rus A (2014) Splicing modulation therapy in the treatment of genetic diseases. Appl Clin Genet 7:245\u2013252. \nhttps:\/\/doi.org\/10.2147\/TACG.S71506","journal-title":"Appl Clin Genet"},{"key":"717_CR4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13059-018-1496-z","volume":"19","author":"A Arzalluz-Luque","year":"2018","unstructured":"Arzalluz-Luque A, Conesa A (2018) Single-cell RNAseq for the study of isoforms-how is that possible? Genome Biol 19:110. \nhttps:\/\/doi.org\/10.1186\/s13059-018-1496-z","journal-title":"Genome Biol"},{"key":"717_CR5","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1093\/hmg\/ddq230","volume":"19","author":"PE Ash","year":"2010","unstructured":"Ash PE et al (2010) Neurotoxic effects of TDP-43 overexpression in C. elegans. Hum Mol Genet 19:3206\u20133218. \nhttps:\/\/doi.org\/10.1093\/hmg\/ddq230","journal-title":"Hum Mol Genet"},{"key":"717_CR6","doi-asserted-by":"publisher","first-page":"10649","DOI":"10.1093\/nar\/gkx709","volume":"45","author":"JK Bailey","year":"2017","unstructured":"Bailey JK, Shen W, Liang XH, Crooke ST (2017) Nucleic acid binding proteins affect the subcellular distribution of phosphorothioate antisense oligonucleotides. Nucleic Acids Res 45:10649\u201310671. \nhttps:\/\/doi.org\/10.1093\/nar\/gkx709","journal-title":"Nucleic Acids Res"},{"key":"717_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1042\/CS20160211","volume":"131","author":"D Baralle","year":"2017","unstructured":"Baralle D, Buratti E (2017) RNA splicing in human disease and in the clinic. Clin Sci 131:355\u2013368. \nhttps:\/\/doi.org\/10.1042\/CS20160211","journal-title":"Clin Sci"},{"key":"717_CR8","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3389\/fncel.2017.00195","volume":"11","author":"HV Barker","year":"2017","unstructured":"Barker HV, Niblock M, Lee YB, Shaw CE, Gallo JM (2017) RNA misprocessing in C9orf72-linked neurodegeneration. Front Cell Neurosci 11:195. \nhttps:\/\/doi.org\/10.3389\/fncel.2017.00195","journal-title":"Front Cell Neurosci"},{"key":"717_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12953-015-0065-6","volume":"13","author":"FL Basei","year":"2015","unstructured":"Basei FL, Meirelles GV, Righetto GL, Dos Santos Migueleti DL, Smetana JH, Kobarg J (2015) New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing. Proteome Sci 13:11. \nhttps:\/\/doi.org\/10.1186\/s12953-015-0065-6","journal-title":"Proteome Sci"},{"key":"717_CR10","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1212\/WNL.0b013e3181ed9cde","volume":"75","author":"D Baumer","year":"2010","unstructured":"Baumer D, Hilton D, Paine SM, Turner MR, Lowe J, Talbot K, Ansorge O (2010) Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations. Neurology 75:611\u2013618. \nhttps:\/\/doi.org\/10.1212\/WNL.0b013e3181ed9cde","journal-title":"Neurology"},{"key":"717_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.molcel.2005.04.003","volume":"18","author":"MT Bedford","year":"2005","unstructured":"Bedford MT, Richard S (2005) Arginine methylation an emerging regulator of protein function. Mol Cell 18:263\u2013272. \nhttps:\/\/doi.org\/10.1016\/j.molcel.2005.04.003","journal-title":"Mol Cell"},{"key":"717_CR12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00401-018-1852-9","volume":"136","author":"CL Bennett","year":"2018","unstructured":"Bennett CL et al (2018) Senataxin mutations elicit motor neuron degeneration phenotypes and yield TDP-43 mislocalization in ALS4 mice and human patients. Acta Neuropathol 136:425\u2013443. \nhttps:\/\/doi.org\/10.1007\/s00401-018-1852-9","journal-title":"Acta Neuropathol"},{"key":"717_CR13","doi-asserted-by":"publisher","first-page":"4307","DOI":"10.1038\/s41598-018-21770-7","volume":"8","author":"C Benoit-Pilven","year":"2018","unstructured":"Benoit-Pilven C et al (2018) Complementarity of assembly-first and mapping-first approaches for alternative splicing annotation and differential analysis from RNAseq data. Sci Rep 8:4307. \nhttps:\/\/doi.org\/10.1038\/s41598-018-21770-7","journal-title":"Sci Rep"},{"key":"717_CR14","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/wrna.1347","volume":"7","author":"A Berger","year":"2016","unstructured":"Berger A, Maire S, Gaillard MC, Sahel JA, Hantraye P, Bemelmans AP (2016) mRNA trans-splicing in gene therapy for genetic diseases. Wiley Interdiscip Rev RNA 7:487\u2013498. \nhttps:\/\/doi.org\/10.1002\/wrna.1347","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"717_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.compbiolchem.2016.01.001","volume":"61","author":"VV Bhandare","year":"2016","unstructured":"Bhandare VV, Ramaswamy A (2016) Identification of possible siRNA molecules for TDP43 mutants causing amyotrophic lateral sclerosis: in silico design and molecular dynamics study. Comput Biol Chem 61:97\u2013108. \nhttps:\/\/doi.org\/10.1016\/j.compbiolchem.2016.01.001","journal-title":"Comput Biol Chem"},{"key":"717_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/mrd.22024","volume":"79","author":"E Blackwell","year":"2012","unstructured":"Blackwell E, Ceman S (2012) Arginine methylation of RNA-binding proteins regulates cell function and differentiation. Mol Reprod Dev 79:163\u2013175. \nhttps:\/\/doi.org\/10.1002\/mrd.22024","journal-title":"Mol Reprod Dev"},{"key":"717_CR17","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1517\/14712598.2015.983070","volume":"15","author":"H Borna","year":"2015","unstructured":"Borna H, Imani S, Iman M, Azimzadeh Jamalkandi S (2015) Therapeutic face of RNAi: in vivo challenges. Exp Opin Biol Ther 15:269\u2013285. \nhttps:\/\/doi.org\/10.1517\/14712598.2015.983070","journal-title":"Exp Opin Biol Ther"},{"key":"717_CR18","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1101\/gad.1558107","volume":"21","author":"PL Boutz","year":"2007","unstructured":"Boutz PL et al (2007) A post-transcriptional regulatory switch in polypyrimidine tract-binding proteins reprograms alternative splicing in developing neurons. Genes Dev 21:1636\u20131652. \nhttps:\/\/doi.org\/10.1101\/gad.1558107","journal-title":"Genes Dev"},{"key":"717_CR19","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1093\/brain\/aww033","volume":"139","author":"D Brenner","year":"2016","unstructured":"Brenner D et al (2016) NEK1 mutations in familial amyotrophic lateral sclerosis. Brain 139:e28. \nhttps:\/\/doi.org\/10.1093\/brain\/aww033","journal-title":"Brain"},{"key":"717_CR20","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1093\/brain\/awx370","volume":"141","author":"D Brenner","year":"2018","unstructured":"Brenner D et al (2018) Hot-spot KIF5A mutations cause familial ALS. Brain 141:688\u2013697. \nhttps:\/\/doi.org\/10.1093\/brain\/awx370","journal-title":"Brain"},{"key":"717_CR21","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/ana.410390519","volume":"39","author":"LA Bristol","year":"1996","unstructured":"Bristol LA, Rothstein JD (1996) Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex. Ann Neurol 39:676\u2013679. \nhttps:\/\/doi.org\/10.1002\/ana.410390519","journal-title":"Ann Neurol"},{"key":"717_CR22","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/hmg\/ddx436","volume":"27","author":"SJ Brockmann","year":"2018","unstructured":"Brockmann SJ et al (2018) CHCHD10 mutations p. R15L and p.G66V cause motoneuron disease by haploinsufficiency. Hum Mol Genet 27:706\u2013715. \nhttps:\/\/doi.org\/10.1093\/hmg\/ddx436","journal-title":"Hum Mol Genet"},{"key":"717_CR23","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1001\/archneur.1997.00550220050013","volume":"54","author":"RH Brown Jr","year":"1997","unstructured":"Brown RH Jr (1997) Amyotrophic lateral sclerosis. Insights from genetics. Arch Neurol 54:1246\u20131250","journal-title":"Arch Neurol"},{"key":"717_CR24","doi-asserted-by":"publisher","first-page":"867","DOI":"10.2741\/2727","volume":"13","author":"E Buratti","year":"2008","unstructured":"Buratti E, Baralle FE (2008) Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. Front Biosci 13:867\u2013878","journal-title":"Front Biosci"},{"key":"717_CR25","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3389\/fgene.2018.00712","volume":"9","author":"Z Butti","year":"2018","unstructured":"Butti Z, Patten SA (2018) RNA dysregulation in amyotrophic lateral sclerosis. Front Genet 9:712. \nhttps:\/\/doi.org\/10.3389\/fgene.2018.00712","journal-title":"Front Genet"},{"key":"717_CR26","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1126\/science.aaa3650","volume":"347","author":"ET Cirulli","year":"2015","unstructured":"Cirulli ET et al (2015) Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science 347:1436\u20131441. \nhttps:\/\/doi.org\/10.1126\/science.aaa3650","journal-title":"Science"},{"key":"717_CR27","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.bbagrm.2015.10.015","volume":"1849","author":"C Colombrita","year":"2015","unstructured":"Colombrita C et al (2015) From transcriptomic to protein level changes in TDP-43 and FUS loss-of-function cell models. Biochem Biophys Acta 1849:1398\u20131410. \nhttps:\/\/doi.org\/10.1016\/j.bbagrm.2015.10.015","journal-title":"Biochem Biophys Acta"},{"key":"717_CR28","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1101\/gad.304055.117","volume":"31","author":"EG Conlon","year":"2017","unstructured":"Conlon EG, Manley JL (2017) RNA-binding proteins in neurodegeneration: mechanisms in aggregate. Genes Dev 31:1509\u20131528. \nhttps:\/\/doi.org\/10.1101\/gad.304055.117","journal-title":"Genes Dev"},{"key":"717_CR29","doi-asserted-by":"publisher","DOI":"10.7554\/elife.17820","author":"EG Conlon","year":"2016","unstructured":"Conlon EG, Lu L, Sharma A, Yamazaki T, Tang T, Shneider NA, Manley JL (2016) The C9ORF72 GGGGCC expansion forms RNA G-quadruplex inclusions and sequesters hnRNP H to disrupt splicing in ALS brains. eLife. \nhttps:\/\/doi.org\/10.7554\/elife.17820","journal-title":"eLife"},{"key":"717_CR30","doi-asserted-by":"publisher","DOI":"10.7554\/elife.37754","author":"EG Conlon","year":"2018","unstructured":"Conlon EG et al (2018) Unexpected similarities between C9ORF72 and sporadic forms of ALS\/FTD suggest a common disease mechanism. eLife. \nhttps:\/\/doi.org\/10.7554\/elife.37754","journal-title":"eLife"},{"key":"717_CR31","doi-asserted-by":"publisher","first-page":"e0127376","DOI":"10.1371\/journal.pone.0127376","volume":"10","author":"J Cooper-Knock","year":"2015","unstructured":"Cooper-Knock J et al (2015) C9ORF72 GGGGCC expanded repeats produce splicing dysregulation which correlates with disease severity in amyotrophic lateral sclerosis. PLoS ONE 10:e0127376. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0127376","journal-title":"PLoS ONE"},{"key":"717_CR32","doi-asserted-by":"publisher","first-page":"e1004704","DOI":"10.1371\/journal.pgen.1004704","volume":"10","author":"J Couthouis","year":"2014","unstructured":"Couthouis J, Raphael AR, Daneshjou R, Gitler AD (2014) Targeted exon capture and sequencing in sporadic amyotrophic lateral sclerosis. PLoS Genet 10:e1004704. \nhttps:\/\/doi.org\/10.1371\/journal.pgen.1004704","journal-title":"PLoS Genet"},{"key":"717_CR33","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1136\/jnnp.2011.242313","volume":"82","author":"R Del Bo","year":"2011","unstructured":"Del Bo R et al (2011) Novel optineurin mutations in patients with familial and sporadic amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 82:1239\u20131243. \nhttps:\/\/doi.org\/10.1136\/jnnp.2011.242313","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"717_CR34","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1093\/brain\/awy062","volume":"141","author":"JE Deshaies","year":"2018","unstructured":"Deshaies JE et al (2018) TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis. Brain 141:1320\u20131333. \nhttps:\/\/doi.org\/10.1093\/brain\/awy062","journal-title":"Brain"},{"key":"717_CR35","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.neuron.2013.10.015","volume":"80","author":"CJ Donnelly","year":"2013","unstructured":"Donnelly CJ et al (2013) RNA toxicity from the ALS\/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron 80:415\u2013428. \nhttps:\/\/doi.org\/10.1016\/j.neuron.2013.10.015","journal-title":"Neuron"},{"key":"717_CR36","doi-asserted-by":"publisher","first-page":"14741","DOI":"10.1038\/ncomms14741","volume":"8","author":"L Errichelli","year":"2017","unstructured":"Errichelli L et al (2017) FUS affects circular RNA expression in murine embryonic stem cell-derived motor neurons. Nat Commun 8:14741. \nhttps:\/\/doi.org\/10.1038\/ncomms14741","journal-title":"Nat Commun"},{"key":"717_CR37","doi-asserted-by":"publisher","first-page":"33504","DOI":"10.1074\/jbc.274.47.33504","volume":"274","author":"LL Furge","year":"1999","unstructured":"Furge LL, Chen K, Cohen S (1999) Annexin VII and annexin XI are tyrosine phosphorylated in peroxovanadate-treated dogs and in platelet-derived growth factor-treated rat vascular smooth muscle cells. J Biol Chem 274:33504\u201333509","journal-title":"J Biol Chem"},{"key":"717_CR38","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00439-016-1683-5","volume":"135","author":"T Geuens","year":"2016","unstructured":"Geuens T, Bouhy D, Timmerman V (2016) The hnRNP family: insights into their role in health and disease. Hum Genet 135:851\u2013867. \nhttps:\/\/doi.org\/10.1007\/s00439-016-1683-5","journal-title":"Hum Genet"},{"key":"717_CR39","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S1474-4422(11)70261-7","volume":"11","author":"I Gijselinck","year":"2012","unstructured":"Gijselinck I et al (2012) A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol 11:54\u201365. \nhttps:\/\/doi.org\/10.1016\/S1474-4422(11)70261-7","journal-title":"Lancet Neurol"},{"key":"717_CR40","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0092-8674(00)81399-9","volume":"92","author":"PJ Grabowski","year":"1998","unstructured":"Grabowski PJ (1998) Splicing regulation in neurons: tinkering with cell-specific control. Cell 92:709\u2013712","journal-title":"Cell"},{"key":"717_CR41","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/ng1742","volume":"38","author":"MJ Greenway","year":"2006","unstructured":"Greenway MJ et al (2006) ANG mutations segregate with familial and \u2018sporadic\u2019 amyotrophic lateral sclerosis. Nat Genet 38:411\u2013413. \nhttps:\/\/doi.org\/10.1038\/ng1742","journal-title":"Nat Genet"},{"key":"717_CR42","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1042\/BCJ20160499","volume":"474","author":"AF Harrison","year":"2017","unstructured":"Harrison AF, Shorter J (2017) RNA-binding proteins with prion-like domains in health and disease. Biochem J 474:1417\u20131438. \nhttps:\/\/doi.org\/10.1042\/BCJ20160499","journal-title":"Biochem J"},{"key":"717_CR43","doi-asserted-by":"publisher","first-page":"6549","DOI":"10.1093\/nar\/gkw533","volume":"44","author":"MA Havens","year":"2016","unstructured":"Havens MA, Hastings ML (2016) Splice-switching antisense oligonucleotides as therapeutic drugs. Nucleic Acids Res 44:6549\u20136563. \nhttps:\/\/doi.org\/10.1093\/nar\/gkw533","journal-title":"Nucleic Acids Res"},{"key":"717_CR44","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/nature16959","volume":"530","author":"Y He","year":"2016","unstructured":"He Y, Zeng MY, Yang D, Motro B, Nunez G (2016) NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature 530:354\u2013357. \nhttps:\/\/doi.org\/10.1038\/nature16959","journal-title":"Nature"},{"key":"717_CR45","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.nbd.2011.12.033","volume":"45","author":"T Hideyama","year":"2012","unstructured":"Hideyama T, Yamashita T, Aizawa H, Tsuji S, Kakita A, Takahashi H, Kwak S (2012) Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons. Neurobiol Dis 45:1121\u20131128. \nhttps:\/\/doi.org\/10.1016\/j.nbd.2011.12.033","journal-title":"Neurobiol Dis"},{"key":"717_CR46","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/ng.198","volume":"40","author":"S Hofmann","year":"2008","unstructured":"Hofmann S et al (2008) Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis. Nat Genet 40:1103\u20131106. \nhttps:\/\/doi.org\/10.1038\/ng.198","journal-title":"Nat Genet"},{"key":"717_CR47","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1101\/gr.231209.117","volume":"28","author":"YE Hsiao","year":"2018","unstructured":"Hsiao YE et al (2018) RNA editing in nascent RNA affects pre-mRNA splicing. Genome Res 28:812\u2013823. \nhttps:\/\/doi.org\/10.1101\/gr.231209.117","journal-title":"Genome Res"},{"key":"717_CR48","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s12010-013-0155-9","volume":"170","author":"M Hu","year":"2013","unstructured":"Hu M, Guo Y, Chen H, Duan W, Li C (2013) Exon array analysis of alternative splicing of genes in SOD1G93A transgenic mice. Appl Biochem Biotechnol 170:301\u2013319. \nhttps:\/\/doi.org\/10.1007\/s12010-013-0155-9","journal-title":"Appl Biochem Biotechnol"},{"key":"717_CR49","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s12276-018-0071-8","volume":"50","author":"B Hwang","year":"2018","unstructured":"Hwang B, Lee JH, Bang D (2018) Single-cell RNA sequencing technologies and bioinformatics pipelines. Exp Mol Med 50:96. \nhttps:\/\/doi.org\/10.1038\/s12276-018-0071-8","journal-title":"Exp Mol Med"},{"key":"717_CR50","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/srep00529","volume":"2","author":"S Ishigaki","year":"2012","unstructured":"Ishigaki S et al (2012) Position-dependent FUS-RNA interactions regulate alternative splicing events and transcriptions. Sci Rep 2:529. \nhttps:\/\/doi.org\/10.1038\/srep00529","journal-title":"Sci Rep"},{"key":"717_CR51","doi-asserted-by":"publisher","first-page":"4136","DOI":"10.1093\/hmg\/ddt262","volume":"22","author":"T Ishihara","year":"2013","unstructured":"Ishihara T et al (2013) Decreased number of Gemini of coiled bodies and U12 snRNA level in amyotrophic lateral sclerosis. Hum Mol Genet 22:4136\u20134147. \nhttps:\/\/doi.org\/10.1093\/hmg\/ddt262","journal-title":"Hum Mol Genet"},{"key":"717_CR52","doi-asserted-by":"publisher","first-page":"20329","DOI":"10.1074\/jbc.M109.010264","volume":"284","author":"BS Johnson","year":"2009","unstructured":"Johnson BS, Snead D, Lee JJ, McCaffery JM, Shorter J, Gitler AD (2009) TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J Biol Chem 284:20329\u201320339. \nhttps:\/\/doi.org\/10.1074\/jbc.M109.010264","journal-title":"J Biol Chem"},{"issue":"2948","key":"717_CR53","doi-asserted-by":"publisher","first-page":"e2915","DOI":"10.1016\/j.neurobiolaging.2012.06.023","volume":"33","author":"L Johnson","year":"2012","unstructured":"Johnson L et al (2012) Screening for OPTN mutations in a cohort of British amyotrophic lateral sclerosis patients. Neurobiol Aging 33(2948):e2915\u2013e2947. \nhttps:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.06.023","journal-title":"Neurobiol Aging"},{"key":"717_CR54","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/14728222.2018.1417390","volume":"22","author":"N Jyotsana","year":"2018","unstructured":"Jyotsana N, Heuser M (2018) Exploiting differential RNA splicing patterns: a potential new group of therapeutic targets in cancer. Exp Opin Ther Targets 22:107\u2013121. \nhttps:\/\/doi.org\/10.1080\/14728222.2018.1417390","journal-title":"Exp Opin Ther Targets"},{"key":"717_CR55","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/ng.132","volume":"40","author":"E Kabashi","year":"2008","unstructured":"Kabashi E et al (2008) TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 40:572\u2013574. \nhttps:\/\/doi.org\/10.1038\/ng.132","journal-title":"Nat Genet"},{"key":"717_CR56","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s12035-009-8054-3","volume":"39","author":"K Kanekura","year":"2009","unstructured":"Kanekura K, Suzuki H, Aiso S, Matsuoka M (2009) ER stress and unfolded protein response in amyotrophic lateral sclerosis. Mol Neurobiol 39:81\u201389. \nhttps:\/\/doi.org\/10.1007\/s12035-009-8054-3","journal-title":"Mol Neurobiol"},{"key":"717_CR57","doi-asserted-by":"publisher","first-page":"12143","DOI":"10.1038\/ncomms12143","volume":"7","author":"K Kapeli","year":"2016","unstructured":"Kapeli K et al (2016) Distinct and shared functions of ALS-associated proteins TDP-43, FUS and TAF15 revealed by multisystem analyses. Nat Commun 7:12143. \nhttps:\/\/doi.org\/10.1038\/ncomms12143","journal-title":"Nat Commun"},{"key":"717_CR58","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s00439-017-1830-7","volume":"136","author":"K Kapeli","year":"2017","unstructured":"Kapeli K, Martinez FJ, Yeo GW (2017) Genetic mutations in RNA-binding proteins and their roles in ALS. Hum Genet 136:1193\u20131214. \nhttps:\/\/doi.org\/10.1007\/s00439-017-1830-7","journal-title":"Hum Genet"},{"key":"717_CR59","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/ng.3626","volume":"48","author":"KP Kenna","year":"2016","unstructured":"Kenna KP et al (2016) NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. Nat Genet 48:1037\u20131042. \nhttps:\/\/doi.org\/10.1038\/ng.3626","journal-title":"Nat Genet"},{"key":"717_CR60","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41593-018-0300-4","volume":"22","author":"JR Klim","year":"2019","unstructured":"Klim JR et al (2019) ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat Neurosci 22:167\u2013179. \nhttps:\/\/doi.org\/10.1038\/s41593-018-0300-4","journal-title":"Nat Neurosci"},{"key":"717_CR61","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-013-1160-7","author":"M Kuzma-Kozakiewicz","year":"2013","unstructured":"Kuzma-Kozakiewicz M, Chudy A, Kazmierczak B, Dziewulska D, Usarek E, Baranczyk-Kuzma A (2013) Dynactin deficiency in the CNS of humans with sporadic ALS and mice with genetically determined motor neuron degeneration. Neurochem Res. \nhttps:\/\/doi.org\/10.1007\/s11064-013-1160-7","journal-title":"Neurochem Res"},{"key":"717_CR62","doi-asserted-by":"publisher","DOI":"10.1007\/s10048-015-0449-x","author":"V La Cognata","year":"2015","unstructured":"La Cognata V, D\u2019Agata V, Cavalcanti F, Cavallaro S (2015) Splicing: is there an alternative contribution to Parkinson\u2019s disease? Neurogenetics. \nhttps:\/\/doi.org\/10.1007\/s10048-015-0449-x","journal-title":"Neurogenetics"},{"key":"717_CR63","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10048-016-0494-0","volume":"17","author":"V La Cognata","year":"2016","unstructured":"La Cognata V, Morello G, Gentile G, D\u2019Agata V, Criscuolo C, Cavalcanti F, Cavallaro S (2016) A customized high-resolution array-comparative genomic hybridization to explore copy number variations in Parkinson\u2019s disease. Neurogenetics 17:233\u2013244. \nhttps:\/\/doi.org\/10.1007\/s10048-016-0494-0","journal-title":"Neurogenetics"},{"key":"717_CR64","doi-asserted-by":"publisher","first-page":"R46","DOI":"10.1093\/hmg\/ddq137","volume":"19","author":"C Lagier-Tourenne","year":"2010","unstructured":"Lagier-Tourenne C, Polymenidou M, Cleveland DW (2010) TDP-43 and FUS\/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet 19:R46\u2013R64. \nhttps:\/\/doi.org\/10.1093\/hmg\/ddq137","journal-title":"Hum Mol Genet"},{"key":"717_CR65","doi-asserted-by":"publisher","first-page":"E4530","DOI":"10.1073\/pnas.1318835110","volume":"110","author":"C Lagier-Tourenne","year":"2013","unstructured":"Lagier-Tourenne C et al (2013) Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Proc Natl Acad Sci USA 110:E4530\u2013E4539. \nhttps:\/\/doi.org\/10.1073\/pnas.1318835110","journal-title":"Proc Natl Acad Sci USA"},{"key":"717_CR66","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S0896-6273(02)00696-7","volume":"34","author":"BH LaMonte","year":"2002","unstructured":"LaMonte BH et al (2002) Disruption of dynein\/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron 34:715\u2013727","journal-title":"Neuron"},{"key":"717_CR67","doi-asserted-by":"publisher","first-page":"e1001611","DOI":"10.1371\/journal.pbio.1001611","volume":"11","author":"JE Lazarus","year":"2013","unstructured":"Lazarus JE, Moughamian AJ, Tokito MK, Holzbaur EL (2013) Dynactin subunit p150(Glued) is a neuron-specific anti-catastrophe factor. PLoS Biol 11:e1001611. \nhttps:\/\/doi.org\/10.1371\/journal.pbio.1001611","journal-title":"PLoS Biol"},{"key":"717_CR68","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.celrep.2013.10.049","volume":"5","author":"YB Lee","year":"2013","unstructured":"Lee YB et al (2013) Hexanucleotide repeats in ALS\/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic. Cell Rep 5:1178\u20131186. \nhttps:\/\/doi.org\/10.1016\/j.celrep.2013.10.049","journal-title":"Cell Rep"},{"key":"717_CR69","doi-asserted-by":"publisher","first-page":"6398","DOI":"10.1093\/nar\/gkw325","volume":"44","author":"K Licht","year":"2016","unstructured":"Licht K, Kapoor U, Mayrhofer E, Jantsch MF (2016) Adenosine to inosine editing frequency controlled by splicing efficiency. Nucleic Acids Res 44:6398\u20136408. \nhttps:\/\/doi.org\/10.1093\/nar\/gkw325","journal-title":"Nucleic Acids Res"},{"key":"717_CR70","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S0896-6273(00)80997-6","volume":"20","author":"CL Lin","year":"1998","unstructured":"Lin CL, Bristol LA, Jin L, Dykes-Hoberg M, Crawford T, Clawson L, Rothstein JD (1998) Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 20:589\u2013602","journal-title":"Neuron"},{"key":"717_CR71","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1515\/aiht-2015-66-2679","volume":"66","author":"RM Liscic","year":"2015","unstructured":"Liscic RM (2015) Molecular basis of ALS and FTD: implications for translational studies. Arh Hig Rada Toksikol 66:285\u2013290. \nhttps:\/\/doi.org\/10.1515\/aiht-2015-66-2679","journal-title":"Arh Hig Rada Toksikol"},{"key":"717_CR72","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3109\/17482960903545334","volume":"11","author":"AC Ludolph","year":"2010","unstructured":"Ludolph AC et al (2010) Guidelines for preclinical animal research in ALS\/MND: a consensus meeting. Amyotroph Lateral Scler 11:38\u201345. \nhttps:\/\/doi.org\/10.3109\/17482960903545334","journal-title":"Amyotroph Lateral Scler"},{"key":"717_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04373-8","author":"R Luisier","year":"2018","unstructured":"Luisier R et al (2018) Intron retention and nuclear loss of SFPQ are molecular hallmarks of ALS. Nat Commun. \nhttps:\/\/doi.org\/10.1038\/s41467-018-04373-8","journal-title":"Nat Commun"},{"key":"717_CR74","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.brainres.2011.12.010","volume":"1462","author":"IR Mackenzie","year":"2012","unstructured":"Mackenzie IR, Neumann M (2012) FET proteins in frontotemporal dementia and amyotrophic lateral sclerosis. Brain Res 1462:40\u201343. \nhttps:\/\/doi.org\/10.1016\/j.brainres.2011.12.010","journal-title":"Brain Res"},{"key":"717_CR75","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nature08971","volume":"465","author":"H Maruyama","year":"2010","unstructured":"Maruyama H et al (2010) Mutations of optineurin in amyotrophic lateral sclerosis. Nature 465:223\u2013226. \nhttps:\/\/doi.org\/10.1038\/nature08971","journal-title":"Nature"},{"key":"717_CR76","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrm3742","volume":"15","author":"AG Matera","year":"2014","unstructured":"Matera AG, Wang Z (2014) A day in the life of the spliceosome. Nat Rev Mol Cell Biol 15:108\u2013121. \nhttps:\/\/doi.org\/10.1038\/nrm3742","journal-title":"Nat Rev Mol Cell Biol"},{"key":"717_CR77","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.1172\/JCI99081","volume":"128","author":"A McCampbell","year":"2018","unstructured":"McCampbell A et al (2018) Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models. J Clin Investig 128:3558\u20133567. \nhttps:\/\/doi.org\/10.1172\/JCI99081","journal-title":"J Clin Investig"},{"key":"717_CR78","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.coph.2015.07.005","volume":"24","author":"G McClorey","year":"2015","unstructured":"McClorey G, Wood MJ (2015) An overview of the clinical application of antisense oligonucleotides for RNA-targeting therapies. Curr Opin Pharmacol 24:52\u201358. \nhttps:\/\/doi.org\/10.1016\/j.coph.2015.07.005","journal-title":"Curr Opin Pharmacol"},{"key":"717_CR79","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1179\/1743132812Y.0000000092","volume":"34","author":"DM Mendonca","year":"2012","unstructured":"Mendonca DM et al (2012) Neuroproteomics: an insight into ALS. Neurol Res 34:937\u2013943. \nhttps:\/\/doi.org\/10.1179\/1743132812Y.0000000092","journal-title":"Neurol Res"},{"key":"717_CR80","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S1474-4422(13)70061-9","volume":"12","author":"TM Miller","year":"2013","unstructured":"Miller TM et al (2013) An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study. Lancet Neurol 12:435\u2013442. \nhttps:\/\/doi.org\/10.1016\/S1474-4422(13)70061-9","journal-title":"Lancet Neurol"},{"key":"717_CR81","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1747-1028-6-18","volume":"6","author":"L Moniz","year":"2011","unstructured":"Moniz L, Dutt P, Haider N, Stambolic V (2011) Nek family of kinases in cell cycle, checkpoint control and cancer. Cell Div 6:18. \nhttps:\/\/doi.org\/10.1186\/1747-1028-6-18","journal-title":"Cell Div"},{"key":"717_CR82","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-017-0393-x","author":"G Morello","year":"2017","unstructured":"Morello G, Guarnaccia M, Spampinato AG, La Cognata V, D\u2019Agata V, Cavallaro S (2017) Copy number variations in amyotrophic lateral sclerosis: piecing the mosaic tiles together through a systems biology approach. Mol Neurobiol. \nhttps:\/\/doi.org\/10.1007\/s12035-017-0393-x","journal-title":"Mol Neurobiol"},{"key":"717_CR83","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00401-013-1088-7","volume":"125","author":"K Mori","year":"2013","unstructured":"Mori K et al (2013) hnRNP A3 binds to GGGGCC repeats and is a constituent of p62-positive\/TDP43-negative inclusions in the hippocampus of patients with C9orf72 mutations. Acta Neuropathol 125:413\u2013423. \nhttps:\/\/doi.org\/10.1007\/s00401-013-1088-7","journal-title":"Acta Neuropathol"},{"key":"717_CR84","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0378-1119(98)00463-6","volume":"221","author":"F Morohoshi","year":"1998","unstructured":"Morohoshi F, Ootsuka Y, Arai K, Ichikawa H, Mitani S, Munakata N, Ohki M (1998) Genomic structure of the human RBP56\/hTAFII68 and FUS\/TLS genes. Gene 221:191\u2013198","journal-title":"Gene"},{"key":"717_CR85","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1212\/01.WNL.0000134608.83927.B1","volume":"63","author":"C Munch","year":"2004","unstructured":"Munch C et al (2004) Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology 63:724\u2013726","journal-title":"Neurology"},{"key":"717_CR86","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/ana.20631","volume":"58","author":"C Munch","year":"2005","unstructured":"Munch C et al (2005) Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD. Ann Neurol 58:777\u2013780. \nhttps:\/\/doi.org\/10.1002\/ana.20631","journal-title":"Ann Neurol"},{"key":"717_CR87","doi-asserted-by":"publisher","first-page":"12901","DOI":"10.1038\/s41598-018-31078-1","volume":"8","author":"F Mure","year":"2018","unstructured":"Mure F, Corbin A, Benbahouche NEH, Bertrand E, Manet E, Gruffat H (2018) The splicing factor SRSF3 is functionally connected to the nuclear RNA exosome for intronless mRNA decay. Sci Rep 8:12901. \nhttps:\/\/doi.org\/10.1038\/s41598-018-31078-1","journal-title":"Sci Rep"},{"key":"717_CR88","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.bbrc.2010.03.055","volume":"394","author":"T Nachreiner","year":"2010","unstructured":"Nachreiner T, Esser M, Tenten V, Troost D, Weis J, Kruttgen A (2010) Novel splice variants of the amyotrophic lateral sclerosis-associated gene VAPB expressed in human tissues. Biochem Biophys Res Commun 394:703\u2013708. \nhttps:\/\/doi.org\/10.1016\/j.bbrc.2010.03.055","journal-title":"Biochem Biophys Res Commun"},{"key":"717_CR89","doi-asserted-by":"publisher","first-page":"3218","DOI":"10.1093\/nar\/gkt1307","volume":"42","author":"C Naro","year":"2014","unstructured":"Naro C, Barbagallo F, Chieffi P, Bourgeois CF, Paronetto MP, Sette C (2014) The centrosomal kinase NEK2 is a novel splicing factor kinase involved in cell survival. Nucleic Acids Res 42:3218\u20133227. \nhttps:\/\/doi.org\/10.1093\/nar\/gkt1307","journal-title":"Nucleic Acids Res"},{"issue":"1268\u20131283","key":"717_CR90","doi-asserted-by":"publisher","first-page":"e1266","DOI":"10.1016\/j.neuron.2018.02.027","volume":"97","author":"A Nicolas","year":"2018","unstructured":"Nicolas A et al (2018) Genome-wide analyses identify KIF5A as a novel ALS. Gene Neuron 97(1268\u20131283):e1266. \nhttps:\/\/doi.org\/10.1016\/j.neuron.2018.02.027","journal-title":"Gene Neuron"},{"key":"717_CR91","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/14712598.2017.1271872","volume":"17","author":"EH Niks","year":"2017","unstructured":"Niks EH, Aartsma-Rus A (2017) Exon skipping: a first in class strategy for Duchenne muscular dystrophy. Exp Opin Biol Ther 17:225\u2013236. \nhttps:\/\/doi.org\/10.1080\/14712598.2017.1271872","journal-title":"Exp Opin Biol Ther"},{"key":"717_CR92","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.tig.2005.07.005","volume":"21","author":"M Nissim-Rafinia","year":"2005","unstructured":"Nissim-Rafinia M, Kerem B (2005) The splicing machinery is a genetic modifier of disease severity. Trends Genet 21:480\u2013483. \nhttps:\/\/doi.org\/10.1016\/j.tig.2005.07.005","journal-title":"Trends Genet"},{"key":"717_CR93","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/brain\/awp325","volume":"133","author":"A Orlacchio","year":"2010","unstructured":"Orlacchio A et al (2010) SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis. Brain 133:591\u2013598. \nhttps:\/\/doi.org\/10.1093\/brain\/awp325","journal-title":"Brain"},{"key":"717_CR94","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.addr.2015.01.007","volume":"87","author":"G Ozcan","year":"2015","unstructured":"Ozcan G, Ozpolat B, Coleman RL, Sood AK, Lopez-Berestein G (2015) Preclinical and clinical development of siRNA-based therapeutics. Adv Drug Deliv Rev 87:108\u2013119. \nhttps:\/\/doi.org\/10.1016\/j.addr.2015.01.007","journal-title":"Adv Drug Deliv Rev"},{"key":"717_CR95","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1468-1331.2008.02367.x","volume":"16","author":"T Pippucci","year":"2009","unstructured":"Pippucci T et al (2009) Autosomal recessive hereditary spastic paraplegia with thin corpus callosum: a novel mutation in the SPG11 gene and further evidence for genetic heterogeneity. Eur J Neurol 16:121\u2013126. \nhttps:\/\/doi.org\/10.1111\/j.1468-1331.2008.02367.x","journal-title":"Eur J Neurol"},{"key":"717_CR96","doi-asserted-by":"publisher","first-page":"6991","DOI":"10.1128\/MCB.19.10.6991","volume":"19","author":"J Prasad","year":"1999","unstructured":"Prasad J, Colwill K, Pawson T, Manley JL (1999) The protein kinase Clk\/Sty directly modulates SR protein activity: both hyper- and hypophosphorylation inhibit splicing. Mol Cell Biol 19:6991\u20137000","journal-title":"Mol Cell Biol"},{"key":"717_CR97","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/nn.4065","volume":"18","author":"M Prudencio","year":"2015","unstructured":"Prudencio M et al (2015) Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS. Nat Neurosci 18:1175\u20131182. \nhttps:\/\/doi.org\/10.1038\/nn.4065","journal-title":"Nat Neurosci"},{"key":"717_CR98","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.tig.2006.10.002","volume":"23","author":"O Ram","year":"2007","unstructured":"Ram O, Ast G (2007) SR proteins: a foot on the exon before the transition from intron to exon definition. Trends Genet 23:5\u20137. \nhttps:\/\/doi.org\/10.1016\/j.tig.2006.10.002","journal-title":"Trends Genet"},{"key":"717_CR99","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.15252\/embj.201593791","volume":"35","author":"S Reber","year":"2016","unstructured":"Reber S et al (2016) Minor intron splicing is regulated by FUS and affected by ALS-associated FUS mutants. EMBO J 35:1504\u20131521. \nhttps:\/\/doi.org\/10.15252\/embj.201593791","journal-title":"EMBO J"},{"key":"717_CR100","doi-asserted-by":"publisher","first-page":"5692","DOI":"10.1039\/c7sc01336a","volume":"8","author":"X Ren","year":"2017","unstructured":"Ren X, Deng R, Wang L, Zhang K, Li J (2017) RNA splicing process analysis for identifying antisense oligonucleotide inhibitors with padlock probe-based isothermal amplification. Chem Sci 8:5692\u20135698. \nhttps:\/\/doi.org\/10.1039\/c7sc01336a","journal-title":"Chem Sci"},{"key":"717_CR101","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3389\/fnins.2017.00544","volume":"11","author":"H Rindt","year":"2017","unstructured":"Rindt H, Tom CM, Lorson CL, Mattis VB (2017) Optimization of trans-splicing for Huntington\u2019s disease RNA Therapy. Front Neurosci 11:544. \nhttps:\/\/doi.org\/10.3389\/fnins.2017.00544","journal-title":"Front Neurosci"},{"issue":"Suppl 1","key":"717_CR102","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1002\/ana.21543","volume":"65","author":"JD Rothstein","year":"2009","unstructured":"Rothstein JD (2009) Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol 65(Suppl 1):S3\u2013S9. \nhttps:\/\/doi.org\/10.1002\/ana.21543","journal-title":"Ann Neurol"},{"key":"717_CR103","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22040563","author":"V Sardone","year":"2017","unstructured":"Sardone V, Zhou H, Muntoni F, Ferlini A, Falzarano MS (2017) Antisense oligonucleotide-based therapy for neuromuscular disease. Molecules. \nhttps:\/\/doi.org\/10.3390\/molecules22040563","journal-title":"Molecules"},{"key":"717_CR104","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.brainres.2016.03.036","volume":"1647","author":"Y Shang","year":"2016","unstructured":"Shang Y, Huang EJ (2016) Mechanisms of FUS mutations in familial amyotrophic lateral sclerosis. Brain Res 1647:65\u201378. \nhttps:\/\/doi.org\/10.1016\/j.brainres.2016.03.036","journal-title":"Brain Res"},{"key":"717_CR105","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/ni.3333","volume":"17","author":"H Shi","year":"2016","unstructured":"Shi H et al (2016) NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component. Nat Immunol 17:250\u2013258. \nhttps:\/\/doi.org\/10.1038\/ni.3333","journal-title":"Nat Immunol"},{"key":"717_CR106","doi-asserted-by":"publisher","first-page":"e43120","DOI":"10.1371\/journal.pone.0043120","volume":"7","author":"A Shiga","year":"2012","unstructured":"Shiga A et al (2012) Alteration of POLDIP3 splicing associated with loss of function of TDP-43 in tissues affected with ALS. PLoS ONE 7:e43120. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0043120","journal-title":"PLoS ONE"},{"key":"717_CR107","doi-asserted-by":"publisher","first-page":"e25200","DOI":"10.4161\/rdis.25200","volume":"1","author":"J Shorter","year":"2013","unstructured":"Shorter J, Taylor JP (2013) Disease mutations in the prion-like domains of hnRNPA1 and hnRNPA2\/B1 introduce potent steric zippers that drive excess RNP granule assembly. Rare Dis 1:e25200. \nhttps:\/\/doi.org\/10.4161\/rdis.25200","journal-title":"Rare Dis"},{"key":"717_CR108","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/978-1-4939-8651-4_26","volume":"1828","author":"NN Singh","year":"2018","unstructured":"Singh NN, Luo D, Singh RN (2018) Pre-mRNA splicing modulation by antisense oligonucleotides. Methods Mol Biol 1828:415\u2013437. \nhttps:\/\/doi.org\/10.1007\/978-1-4939-8651-4_26","journal-title":"Methods Mol Biol"},{"key":"717_CR109","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/gm508","volume":"5","author":"W Slotkin","year":"2013","unstructured":"Slotkin W, Nishikura K (2013) Adenosine-to-inosine RNA editing and human disease. Genome Med 5:105. \nhttps:\/\/doi.org\/10.1186\/gm508","journal-title":"Genome Med"},{"key":"717_CR110","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aad9157","author":"BN Smith","year":"2017","unstructured":"Smith BN et al (2017) Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis. Sci Transl Med. \nhttps:\/\/doi.org\/10.1126\/scitranslmed.aad9157","journal-title":"Sci Transl Med"},{"key":"717_CR111","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1111\/j.0022-3042.2008.05857.x","volume":"108","author":"H Suzuki","year":"2009","unstructured":"Suzuki H, Kanekura K, Levine TP, Kohno K, Olkkonen VM, Aiso S, Matsuoka M (2009) ALS-linked P56S-VAPB, an aggregated loss-of-function mutant of VAPB, predisposes motor neurons to ER stress-related death by inducing aggregation of co-expressed wild-type VAPB. J Neurochem 108:973\u2013985. \nhttps:\/\/doi.org\/10.1111\/j.0022-3042.2008.05857.x","journal-title":"J Neurochem"},{"key":"717_CR112","doi-asserted-by":"publisher","first-page":"e0131788","DOI":"10.1371\/journal.pone.0131788","volume":"10","author":"A Tawani","year":"2015","unstructured":"Tawani A, Kumar A (2015) structural insights reveal the dynamics of the repeating r(CAG) transcript found in Huntington\u2019s disease (HD) and spinocerebellar ataxias (SCAs). PLoS ONE 10:e0131788. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0131788","journal-title":"PLoS ONE"},{"key":"717_CR113","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bbadis.2008.09.017","volume":"1792","author":"J Tazi","year":"2009","unstructured":"Tazi J, Bakkour N, Stamm S (2009) Alternative splicing and disease. Biochem Biophys Acta 1792:14\u201326. \nhttps:\/\/doi.org\/10.1016\/j.bbadis.2008.09.017","journal-title":"Biochem Biophys Acta"},{"issue":"218","key":"717_CR114","doi-asserted-by":"publisher","first-page":"e211","DOI":"10.1016\/j.neurobiolaging.2016.03.022","volume":"42","author":"E Teyssou","year":"2016","unstructured":"Teyssou E et al (2016) Genetic analysis of CHCHD10 in French familial amyotrophic lateral sclerosis patients. Neurobiol Aging 42(218):e211\u2013e213. \nhttps:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.03.022","journal-title":"Neurobiol Aging"},{"key":"717_CR115","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1080\/15548627.2018.1474311","volume":"14","author":"P Torres","year":"2018","unstructured":"Torres P et al (2018) Cryptic exon splicing function of TARDBP interacts with autophagy in nervous tissue. Autophagy 14:1398\u20131403. \nhttps:\/\/doi.org\/10.1080\/15548627.2018.1474311","journal-title":"Autophagy"},{"key":"717_CR116","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3389\/fnmol.2017.00405","volume":"10","author":"AP Tosolini","year":"2017","unstructured":"Tosolini AP, Sleigh JN (2017) Motor neuron gene therapy: lessons from spinal muscular atrophy for amyotrophic lateral sclerosis. Front Mol Neurosci 10:405. \nhttps:\/\/doi.org\/10.3389\/fnmol.2017.00405","journal-title":"Front Mol Neurosci"},{"key":"717_CR117","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.3389\/fimmu.2018.01017","volume":"9","author":"RP Toth","year":"2018","unstructured":"Toth RP, Atkin JD (2018) Dysfunction of optineurin in amyotrophic lateral sclerosis and glaucoma. Front Immunol 9:1017. \nhttps:\/\/doi.org\/10.3389\/fimmu.2018.01017","journal-title":"Front Immunol"},{"key":"717_CR118","doi-asserted-by":"publisher","first-page":"e00669","DOI":"10.1002\/brb3.669","volume":"7","author":"K Tripolszki","year":"2017","unstructured":"Tripolszki K et al (2017) High-throughput sequencing revealed a novel SETX mutation in a Hungarian patient with amyotrophic lateral sclerosis. Brain Behav 7:e00669. \nhttps:\/\/doi.org\/10.1002\/brb3.669","journal-title":"Brain Behav"},{"key":"717_CR119","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1093\/brain\/aws230","volume":"135","author":"H Tsuji","year":"2012","unstructured":"Tsuji H et al (2012) Molecular analysis and biochemical classification of TDP-43 proteinopathy. Brain 135:3380\u20133391. \nhttps:\/\/doi.org\/10.1093\/brain\/aws230","journal-title":"Brain"},{"key":"717_CR120","doi-asserted-by":"publisher","first-page":"345","DOI":"10.4161\/rna.7.3.12089","volume":"7","author":"S Valadkhan","year":"2010","unstructured":"Valadkhan S (2010) Role of the snRNAs in spliceosomal active site. RNA Biol 7:345\u2013353","journal-title":"RNA Biol"},{"key":"717_CR121","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S1474-4422(08)70071-1","volume":"7","author":"VM Van Deerlin","year":"2008","unstructured":"Van Deerlin VM et al (2008) TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol 7:409\u2013416. \nhttps:\/\/doi.org\/10.1016\/S1474-4422(08)70071-1","journal-title":"Lancet Neurol"},{"key":"717_CR122","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1159\/000354170","volume":"59","author":"T Vanderweyde","year":"2013","unstructured":"Vanderweyde T, Youmans K, Liu-Yesucevitz L, Wolozin B (2013) Role of stress granules and RNA-binding proteins in neurodegeneration: a mini-review. Gerontology 59:524\u2013533. \nhttps:\/\/doi.org\/10.1159\/000354170","journal-title":"Gerontology"},{"key":"717_CR123","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/aian.AIAN_298_17","volume":"21","author":"A Verma","year":"2018","unstructured":"Verma A (2018) Recent advances in antisense oligonucleotide therapy in genetic neuromuscular diseases. Ann Indian Acad Neurol 21:3\u20138. \nhttps:\/\/doi.org\/10.4103\/aian.AIAN_298_17","journal-title":"Ann Indian Acad Neurol"},{"key":"717_CR124","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.semcdb.2017.09.036","volume":"79","author":"B Verma","year":"2018","unstructured":"Verma B, Akinyi MV, Norppa AJ, Frilander MJ (2018) Minor spliceosome and disease. Semin Cell Dev Biol 79:103\u2013112. \nhttps:\/\/doi.org\/10.1016\/j.semcdb.2017.09.036","journal-title":"Semin Cell Dev Biol"},{"key":"717_CR125","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s11825-018-0185-3","volume":"30","author":"AE Volk","year":"2018","unstructured":"Volk AE, Weishaupt JH, Andersen PM, Ludolph AC, Kubisch C (2018) Current knowledge and recent insights into the genetic basis of amyotrophic lateral sclerosis. Med Genet 30:252\u2013258. \nhttps:\/\/doi.org\/10.1007\/s11825-018-0185-3","journal-title":"Med Genet"},{"key":"717_CR126","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1002\/iub.520","volume":"63","author":"AK Walker","year":"2011","unstructured":"Walker AK, Atkin JD (2011) Stress signaling from the endoplasmic reticulum: a central player in the pathogenesis of amyotrophic lateral sclerosis. IUBMB Life 63:754\u2013763. \nhttps:\/\/doi.org\/10.1002\/iub.520","journal-title":"IUBMB Life"},{"key":"717_CR127","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrg2164","volume":"8","author":"GS Wang","year":"2007","unstructured":"Wang GS, Cooper TA (2007) Splicing in disease: disruption of the splicing code and the decoding machinery. Nat Rev Genet 8:749\u2013761. \nhttps:\/\/doi.org\/10.1038\/nrg2164","journal-title":"Nat Rev Genet"},{"key":"717_CR128","doi-asserted-by":"publisher","first-page":"308","DOI":"10.15252\/emmm.201506067","volume":"8","author":"CR Wasser","year":"2016","unstructured":"Wasser CR, Herz J (2016) Splicing therapeutics for Alzheimer\u2019s disease. EMBO Mol Med 8:308\u2013310. \nhttps:\/\/doi.org\/10.15252\/emmm.201506067","journal-title":"EMBO Mol Med"},{"key":"717_CR129","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1093\/hmg\/ddr299","volume":"20","author":"M Wojciechowska","year":"2011","unstructured":"Wojciechowska M, Krzyzosiak WJ (2011) Cellular toxicity of expanded RNA repeats: focus on RNA foci. Hum Mol Genet 20:3811\u20133821. \nhttps:\/\/doi.org\/10.1093\/hmg\/ddr299","journal-title":"Hum Mol Genet"},{"key":"717_CR130","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1093\/emboj\/16.14.4421","volume":"16","author":"S Wu","year":"1997","unstructured":"Wu S, Green MR (1997) Identification of a human protein that recognizes the 3\u2032 splice site during the second step of pre-mRNA splicing. EMBO J 16:4421\u20134432. \nhttps:\/\/doi.org\/10.1093\/emboj\/16.14.4421","journal-title":"EMBO J"},{"key":"717_CR131","doi-asserted-by":"publisher","first-page":"e0187813","DOI":"10.1371\/journal.pone.0187813","volume":"12","author":"M Yahara","year":"2017","unstructured":"Yahara M, Kitamura A, Kinjo M (2017) U6 snRNA expression prevents toxicity in TDP-43-knockdown cells. PLoS ONE 12:e0187813. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0187813","journal-title":"PLoS ONE"},{"key":"717_CR132","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1016\/j.celrep.2017.05.056","volume":"19","author":"S Yin","year":"2017","unstructured":"Yin S et al (2017) Evidence that C9ORF72 dipeptide repeat proteins associate with U2 snRNP to cause mis-splicing in ALS\/FTD patients. Cell Rep 19:2244\u20132256. \nhttps:\/\/doi.org\/10.1016\/j.celrep.2017.05.056","journal-title":"Cell Rep"},{"key":"717_CR133","doi-asserted-by":"publisher","first-page":"a001248","DOI":"10.1101\/mcs.a001248","volume":"2","author":"AC Yu","year":"2016","unstructured":"Yu AC, Chan AY, Au WC, Shen Y, Chan TF, Chan HE (2016) Whole-genome sequencing of two probands with hereditary spastic paraplegia reveals novel splice-donor region variant and known pathogenic variant in SPG11. Cold Spring Harbor Mol Case Stud 2:a001248. \nhttps:\/\/doi.org\/10.1101\/mcs.a001248","journal-title":"Cold Spring Harbor Mol Case Stud"},{"key":"717_CR134","doi-asserted-by":"publisher","first-page":"E4726","DOI":"10.1073\/pnas.1514105112","volume":"112","author":"J Zhang","year":"2015","unstructured":"Zhang J et al (2015) Disease-associated mutation in SRSF2 misregulates splicing by altering RNA-binding affinities. Proc Natl Acad Sci USA 112:E4726\u2013E4734. \nhttps:\/\/doi.org\/10.1073\/pnas.1514105112","journal-title":"Proc Natl Acad Sci USA"},{"key":"717_CR135","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1212\/NXG.0000000000000237","volume":"4","author":"K Zhang","year":"2018","unstructured":"Zhang K et al (2018) ANXA11 mutations prevail in Chinese ALS patients with and without cognitive dementia. Neurol Genet 4:e237. \nhttps:\/\/doi.org\/10.1212\/NXG.0000000000000237","journal-title":"Neurol Genet"},{"key":"717_CR136","doi-asserted-by":"publisher","first-page":"818","DOI":"10.14348\/molcells.2018.0243","volume":"41","author":"M Zhao","year":"2018","unstructured":"Zhao M, Kim JR, van Bruggen R, Park J (2018) RNA-binding proteins in amyotrophic lateral sclerosis. Mol Cells 41:818\u2013829. \nhttps:\/\/doi.org\/10.14348\/molcells.2018.0243","journal-title":"Mol Cells"},{"key":"717_CR137","doi-asserted-by":"publisher","first-page":"e1003895","DOI":"10.1371\/journal.pgen.1003895","volume":"9","author":"Y Zhou","year":"2013","unstructured":"Zhou Y, Liu S, Liu G, Ozturk A, Hicks GG (2013) ALS-associated FUS mutations result in compromised FUS alternative splicing and autoregulation. PLoS Genet 9:e1003895. \nhttps:\/\/doi.org\/10.1371\/journal.pgen.1003895","journal-title":"PLoS Genet"},{"key":"717_CR138","first-page":"2346","volume":"8","author":"LY Zhu","year":"2018","unstructured":"Zhu LY, Zhu YR, Dai DJ, Wang X, Jin HC (2018) Epigenetic regulation of alternative splicing. Am J Cancer Res 8:2346\u20132358","journal-title":"Am J Cancer Res"},{"key":"717_CR139","doi-asserted-by":"publisher","first-page":"190006","DOI":"10.1038\/sdata.2019.6","volume":"6","author":"S Zucca","year":"2019","unstructured":"Zucca S et al (2019) RNA-seq profiling in peripheral blood mononuclear cells of amyotrophic lateral sclerosis patients and controls. Sci Data 6:190006. \nhttps:\/\/doi.org\/10.1038\/sdata.2019.6","journal-title":"Sci Data"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-019-00717-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10571-019-00717-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-019-00717-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T23:38:04Z","timestamp":1596497884000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10571-019-00717-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,5]]},"references-count":139,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["717"],"URL":"https:\/\/doi.org\/10.1007\/s10571-019-00717-0","relation":{},"ISSN":["0272-4340","1573-6830"],"issn-type":[{"value":"0272-4340","type":"print"},{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,5]]},"assertion":[{"value":"9 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}